mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.009 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.009 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.009 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.02 |